Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2005
06/16/2005US20050130178 Thermal cycling protocol for nucleic acid amplification uses two primers with different thermal melting temperatures; polymerase chain reaction (PCR)
06/16/2005US20050130175 Expression vector comprising nucleotide sequences coding mitotic regulatory protein (TOME-1) for use as too in detection prevention and treatment of cell proliferative disorders
06/16/2005US20050130171 Complementary DNA library comprising nucleotide sequences expressed in brain for use as tool in diagnosis, prevention and treatment of cerebral and cognitive functioning disorders
06/16/2005US20050130165 Using presence of single nucleotide polymorphism in sterol-o-acyltransferase (SOAT1) and/or acyl-coenzyme A: cholesterol acyltransferase 1 (ACAT-1) as diagnostic indicator of brain disorders
06/16/2005US20050130164 Generating test strip and/or microarrays comprised of immobilized DNA for use diagnostic tool in gene expression analysis
06/16/2005US20050130163 Surface-enhanced resonance Raman scattering (SERRS) active polymer beads; for use in detecting targect molecules
06/16/2005US20050130161 Identifying gene regulatory elements using methyltransferase and restriction enzyme disgestion; animal toxicity profiles; drug screening
06/16/2005US20050130158 Screening method
06/16/2005US20050130154 Compositions and methods relating to endometrial specific genes and proteins
06/16/2005US20050130152 Method for performing in vitro diagnosis using gene regulation mechanisms and corresponding diagnosis kit
06/16/2005US20050130150 Using allelic variation in growth hormone as tool in diagnosis and treatment of growth hormone irregularities
06/16/2005US20050130146 Histone deactylase for use in identifying modulators for prevention and treatment of cell proliferative disorders
06/16/2005US20050130145 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, and agonists; drug screening
06/16/2005US20050130144 Method of screening reprogramming factor, reprogramming factor screened by the method, method of using the reprogramming factor, method of differentiating undifferentiated fused cells and method of constructing cell, tissues and organs
06/16/2005US20050130143 Human smooth muscle myosin heavy chain polypeptide (hSMMyHC 7polypeptide) for use as tool in identifying modulator for prevention and treatment of hypertension, hypotension, heart and respiratory disorders
06/16/2005US20050130136 Cardiovascular disease diagnostic and therapeutic targets
06/16/2005US20050130135 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof
06/16/2005US20050130132 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
06/16/2005US20050130131 Contacting macrophages in vitro with composition comprising hepatitis c viral particles, culture cells, incubate with non-macrophage cells, culture, recover viral particles; viricides and rational drug design
06/16/2005US20050130127 Coronavirus-like particles comprising functionally deleted genomes
06/16/2005US20050130120 Devices for the detection of multiple analytes in a sample
06/16/2005US20050130119 Real-time impedance assay to follow the invasive activities of metastatic cells in culture
06/16/2005US20050130118 Methods for identifying inhibitors of chlorophyll synthase
06/16/2005US20050130117 Using serine/threonine kinase screening tool in detection of modulator for prevention and treatment of inflammatory, respiratory, allergic and autoimmune diseases
06/16/2005US20050130116 Test system comprising cells expressing polymorphic cytochrome p450 for use as drug and toxicological screening tools; bioassay; rational drug design
06/16/2005US20050129947 Semiconductors; light emitting diodes; salt formation using anion and cation
06/16/2005US20050129822 Determination of dough development using near infrared radiation
06/16/2005US20050129717 Novel uses
06/16/2005US20050129701 Antibody to latent membrane proteins and uses thereof
06/16/2005US20050129700 comprises antibodies against Smallpox Inhibitor of Complement Enzyme (SPICE) or Vaccinia Virus Complement Control Protein (VCP); dna vaccines
06/16/2005US20050129697 Methods of therapy and diagnosis using targeting of cells that express BCLP polypeptides
06/16/2005US20050129690 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
06/16/2005US20050129682 Receptor for Advanced Glycation Endproducts (RAGE); rheumatoid arthritis; solubility
06/16/2005US20050129681 Inhibiting endothelial cell adhesion and migration; limit specific binding of integrin alpha 4 beta 1; antitumor
06/16/2005US20050129678 Using computer modeling to postulate amino acid composition of protein binding sites; bioinformatic and rational drug design
06/16/2005US20050129657 Interferon-alpha induced gene
06/16/2005US20050129618 Screening method for active ingredients; contacting stem cell factor SCF-expressing cells with test ingredients, assaying the amount of SCF produced
06/16/2005US20050129617 Contacting a T lymphocyte from the patient with a diagnostic epitope of an amino acid string including hydrophilic amino acids and one of Leucine, Methionine, Isoleucine, Phenylalanine, Alanine, Glycine, Valine, or Tryptophan
06/16/2005US20050129615 Non-invasive system for detecting skin cancer
06/16/2005US20050129578 analysis apparatus for high spped detection of nonvacuum assisted detectible oxides, comprising sample and oxidizer supply units, furnaces, detection chambers and detectors; monitoring effluents
06/16/2005US20050129575 measuring concentration of metals in solution in a liquid process or liquid waste stream, using automatic controllers to deliver liquids to chambers, adjust conductivity, record voltage and flush the chambers
06/16/2005US20050129574 Rapid diagnosis device with locking by test strip
06/16/2005US20050129573 detectors comprising nanostructure tubes, wires, fibers or rods disposed over substrates, having electrodes and recognition material configured to interact with carbon dioxide
06/16/2005US20050129572 Has adhesive properties and can be used to make a multi-layered test strip or the composition can be used in the sample wells of microfluidic devices.
06/16/2005US20050129294 Device and method for detecting localization, monitoring, and identification of living organisms in structures
06/16/2005US20050127920 Method and system for impedance measurement of a zeolite-based ammonia sensor
06/16/2005US20050127297 Sensor having a communication device, sensor communication system and method of communicating information from a sensor
06/16/2005US20050127285 Method for the automatic analysis of refuse containing polymers and an automatic analytical device for this purpose
06/16/2005US20050126938 Integrally storable adaptor
06/16/2005US20050126930 Hybrid film type sensor
06/16/2005US20050126915 Accuracy analyzing; electrochemistry detector; glucose test strips
06/16/2005US20050126910 Gas sensor
06/16/2005US20050126480 Immobilizing device
06/16/2005US20050126313 Low flow bailer system
06/16/2005US20050126312 Variable valve apparatus and methods
06/16/2005US20050126300 Testing apparatus and method of deriving Young's modulus from tensile stress/strain relationships
06/16/2005US20050126259 Characterization of mist sprays using a phase-doppler analyzer and an iso-kinetic sampling for validation of scale modeling of water mist fire suppression
06/16/2005DE19964188B4 Atemschutzmaske mit einem Sensor-Mikrosystem mit einem beheizbaren Metalloxidsensor Respirator with a sensor microsystem with a heated metal oxide sensor
06/16/2005DE10354351B3 Verfahren und Vorrichtung zur verbesserten Reinigung einer an paramagnetische Mikropartikel gebundenen Substanz Method and apparatus for improved cleaning of a bound to paramagnetic microparticles substance
06/16/2005DE10353445A1 Spenderbehältnis und Vorratsbehältnis für analytische Verbrauchsmittel Dispenser container and storage container for analytical consumables
06/16/2005DE10353291A1 Device for measuring carbon dioxide content of beverages, useful with e.g. mineral water or beer, to ensure correct content, includes a sensor that is immersed in the beverage
06/16/2005DE10352535A1 Mikrostrukturierte Trennvorrichtung und Verfahren zum Abtrennen von flüssigen Bestandteilen aus einer Partikel enthaltenden Flüssigkeit Microstructured separating device and method for separating liquid components from a liquid containing particles
06/16/2005DE10352511A1 Verwendung von MRP4-Inhibitoren zur Behandlung und/oder Prophylaxe kardiovaskulärer Erkrankungen Use of MRP4-inhibitors for the treatment and / or prophylaxis of cardiovascular diseases
06/16/2005DE10352384A1 Reagenzien enthaltende Membrane und Laminate und Verfahren zu ihrer Herstellung Reagents containing membranes and laminates and processes for their preparation
06/16/2005DE10351627A1 Modulation der Angiogenese durch Bartonella henselae Modulation of angiogenesis by Bartonella henselae
06/16/2005DE10351543A1 Optimizing detection of prions including a pathological form in body fluid or homogenized tissue, precipitates prion protein which is made visible by addition of dye bonded to substrate
06/16/2005DE102004051508A1 Laser micro-dissection method for extraction of microscopic object from biological preparation using image analysis technique for automatic object identifcation and marking of required separation line
06/16/2005DE102004046388A1 Quantifizierung von Nukleinsäuren unter Verwendung von Wachstumskurven Quantification of nucleic acids using growth curves
06/16/2005DE10056802B4 Verfahren zur Detektion von Methylierungszuständen zur toxikologischen Diagnostik A method for the detection of methylation states for diagnosis toxicological
06/16/2005DE10029915B4 Verfahren zum Nachweis von Cytosin-Methylierungen A method for the detection of cytosine methylations
06/16/2005CA2765442A1 Novel centromeric protein shugoshin
06/16/2005CA2764400A1 Novel centromeric protein shugoshin
06/16/2005CA2764298A1 Novel centromeric protein shugoshin
06/16/2005CA2551010A1 Diagnostic methods for therapeutic compounds and methods for monitoring azathioprine therapy
06/16/2005CA2549913A1 Polymorphic cd24 genotypes that are predictive of multiple sclerosis risk and progression
06/16/2005CA2549288A1 Improvements relating to hand held anaytical devices
06/16/2005CA2549212A1 Improvements relating to hand held analytical devices
06/16/2005CA2548942A1 Anti-sars monoclonal antibodies
06/16/2005CA2548582A1 Use of gene ncsag4 for the diagnosis and prevention of neosporosis and as a marker for analysis of the pathogenesis
06/16/2005CA2548440A1 Method of measuring blood component, sensor used in the method, and measuring device
06/16/2005CA2548381A1 Cytolethal distending toxins and detection of campylobacter bacteria using the same as a target
06/16/2005CA2548032A1 Hematocrit and analyte concentration determination
06/16/2005CA2548016A1 Use of limk-1, its analogues and ligands for the production of a medicament against a thrombus formation or blood clotting disease
06/16/2005CA2547639A1 Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists
06/16/2005CA2547613A1 A self-condensing ph sensor
06/16/2005CA2547537A1 Protein nmb0928 and use thereof in pharmaceutical formulations
06/16/2005CA2547355A1 Animal models of pancreatic adenocarcinoma and uses therefor
06/16/2005CA2547317A1 Protein nmb1125 and use thereof in pharmaceutical formulations
06/16/2005CA2547226A1 Use of l-isoaspartyl methyltransferase as longevity marker in seeds
06/16/2005CA2547213A1 Apoptosis-based evaluation of chemosensitivity in cancer patients
06/16/2005CA2547153A1 A respiratory monitoring, diagnostic and therapeutic system
06/16/2005CA2546949A1 Compositions and methods for measuring analyte concentrations
06/16/2005CA2546945A1 Fiber optic device for sensing analytes
06/16/2005CA2546837A1 Method for diagnosing diseases based on levels of anti-glycan antibodies
06/16/2005CA2546796A1 Peptide hormones zalpha48 and zsig97
06/16/2005CA2546123A1 Application of test for residual wax contamination in basestocks to correlate with the low temperature viscometric properties of fully formulated oils
06/16/2005CA2545581A1 Clp-protease as target for herbicides
06/16/2005CA2545477A1 Method of measururing hematocrit (hct), sensor used in the method, and measuring device
06/16/2005CA2545257A1 Simple matrix addressing in a display
06/16/2005CA2544614A1 Artificial receptors including gradients